The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 1040-1046

  Mosnier, L O ^a   Meijers, J C M ^a   Bouma, B N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carboxypeptidase U; Fibrinolysis; Protein C; Protein S; TAFI

Indexed keywords

ACTIVATED PROTEIN C; ANTIBODY; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE B; PROTEIN C; PROTEIN S; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; FIBRINOLYSIS; HUMAN; HUMAN CELL; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; REGULATORY MECHANISM; STIMULATION;

EID: 0034759378     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616531     Document Type: Article

References (50)

1. Protein S and C4b-binding protein; Components involved in the regulation of the protein C anticoagulant pathway
2. Deficiency of protein C in congenital thrombotic disease
3. Hereditary protein S deficiency
4. Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis
5. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
6. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor Va R506Q by activated protein C
7. 562
8. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa
9. Protein S binds to and inhibits factor Xa
10. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C
11. Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII
12. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
13. Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: An independent anticoagulant function of protein S in plasma
14. Regulation of prothrombinase activity by protein S
15. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S
16. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein
17. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the APC mediated inactivation of fVIIIa
18. Regulation of vitamin K-dependent protein S. Inactivation by thrombin
19. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
20. The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation
21. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma
22. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen
23. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits
24. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor
25. Plasma carboxypeptidases as regulators of the plasminogen system
26. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis
27. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis
28. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI - In vivo evidence for a role of factor XI as an anti-fibrinolytic factor
29. Factor XI and protection of the fibrin clot against lysis. A role for the intrinsic pathway of coagulation in fibrinolysis
30. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
31. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin
32. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C
33. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact pathway of coagulation
34. Single bilayer vesicles prepared without sonication. Physico-chemical properties
35. Factor XI activation by meizothrombin: Stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine
36. Two dimensional thin layer chromatographic separation of polar lipids and determinant of phospholipids by phosphorus analysis of spots
37. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down-regulation of TAFI activation
38. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C
39. Elements of the primary structure of thrombomodulin required for efficient TAFI activation
40. Leiden
41. Protein C and fibrinolysis: A link between coagulation and fibrinolysis
42. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro
43. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor
44. Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma
45. The defective downregulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration
46. High levels of coagulation factor XI as a risk factor for venous thrombosis
47. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products block cofactor activity. A potential rapid mechanism for modulation of coagulation
48. Thrombin activable fibrinolysis inhibitor and the risk for deep vein thrombosis
49. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not
50. Plasma procarboxypeptidase U in men with symptomatic coronary artery disease